KPV

KPV is a synthetic tripeptide composed of lysine-proline-valine, derived from the C-terminal sequence of alpha-melanocyte-stimulating hormone (alpha-MSH). Originally identified in research on melanocortin receptor signaling, this three-amino-acid sequence has gained attention for its anti-inflammatory properties, particularly in gastrointestinal contexts [1].\n\nUnlike many botanical compounds with centuries of traditional use, KPV emerged directly from modern peptide research. Scientists discovered that this specific sequence retained much of alpha-MSH's anti-inflammatory activity while being smaller and more targeted. The peptide community began exploring KPV around 2015, primarily focusing on gut health applications based on early research showing its effects on intestinal inflammation and barrier function [2].\n\nToday, people use KPV as part of gut healing protocols, often in combination with other peptides like BPC-157 or standalone for inflammatory conditions. What draws users is its specificity — rather than broad systemic effects, KPV appears to work through precise anti-inflammatory pathways without the side effects associated with conventional anti-inflammatory drugs.